Do Immunogen, Inc. (NASDAQ: IMGN) Fit In A Value Investing Philosophy?
Currently, there are 279.35M common shares owned by the public and among those 272.92M shares have been available to trade. Insiders at the company have transacted a total of 81 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Growing Through Challenges? – Immunogen, Inc. (IMGN)
Currently, there are 279.35M common shares owned by the public and among those 273.02M shares have been available to trade. Insiders at the company have transacted a total of 81 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Immunogen, Inc. (NASDAQ: IMGN): Reassessing Prospects
Immunogen, Inc. (IMGN) concluded trading on Wednesday at a closing price of $29.32, with 5.86 million shares of worth about $171.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 60.70% during that period and on Wednesday, January 31 the price saw a loss […]
Do Immunogen, Inc. (NASDAQ: IMGN) Fit In A Value Investing Philosophy?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 8.57% valued currently at $709.08 million. In addition, Janus […]
Immunogen, Inc. (IMGN) Volatility Spurs A Quest For Clarity
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 8.98% valued currently at $701.91 million. In addition, Janus […]
Handle With Care: Immunogen, Inc. (NASDAQ: IMGN)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 8.98% valued currently at $701.91 million. In addition, Janus […]
Is Immunogen, Inc. (NASDAQ: IMGN) Proving The Doubters Wrong?
The Vanguard Group, Inc. has recently announced that it has increased stake in Immunogen, Inc. (NASDAQ:IMGN) by 17.35%. After grabbing 23.92 million shares, the institutional investor is now in possession of 3.54 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.98% having worth around $701.91 million. Moreover, […]
Immunogen, Inc. (NASDAQ: IMGN): Hunting Genuine Value In Market Debris
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 8.98% valued currently at $701.91 million. In addition, Janus […]
Immunogen, Inc. (NASDAQ: IMGN) – Suitable For Long Term Buy?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 9.61% valued currently at $355.38 million. In addition, Janus […]
Growing Through Challenges? – Immunogen, Inc. (IMGN)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 9.61% valued currently at $355.38 million. In addition, Janus […]
